Wu Z, McGoogan JM (2020) Characteristics of and important lessons. From the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 323(13):1239-1242. https://doi.org/10.1001/jama.2020.2648. PMID: 32091533.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
Article
CAS
PubMed
PubMed Central
Google Scholar
Wong RS, Wu A, To KF et al (2003) Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 326(7403):1358–1362. https://doi.org/10.1136/bmj.326.7403.1358
Article
PubMed
PubMed Central
Google Scholar
Wang L, Li X, Chen H, Yan S, Li D, Li Y, Gong Z (2020) Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan, China. Am J Nephrol (5):1–6. https://doi.org/10.1159/000507471 [published online ahead of print, 2020 Mar 31]
Li B, Yang J, Zhao F (2020) Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 109(5):531–538. https://doi.org/10.1007/s00392-020-01626-9
Article
CAS
PubMed
Google Scholar
Xiong TY, Redwood S, Prendergast B, Chen M (2020) Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J 41(19):1798–1800. https://doi.org/10.1093/eurheartj/ehaa231
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang C, Shi L, Wang FS (2020) Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol 5(5):428–430. https://doi.org/10.1016/S2468-1253(20)30057-1
Article
PubMed
PubMed Central
Google Scholar
Sun J, Aghemo A, Forner A, Valenti L (2020) COVID-19 and liver disease. Liver Int. https://doi.org/10.1111/liv.14470 [published online ahead of print, 2020 Apr 6]
Schaefer EAK, Arvind A, Bloom PP, Chung RT (2020) Interrelationship between coronavirus infection and liver disease. Clin Liver Dis 15(5):175–180. https://doi.org/10.1002/cld.967
Article
Google Scholar
Qiu H, Wander P, Bernstein D, Satapathy SK (2020) Acute on chronic liver failure from novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Liver Int. https://doi.org/10.1111/liv.14506 [published online ahead of print, 2020 May 5]
Große K, Kramer M, Trautwein C, Bruns T (2020) SARS-CoV-2 as an extrahepatic precipitator of acute-on-chronic liver failure. Liver Int 40(7):1792–1793. https://doi.org/10.1111/liv.14540 [published online ahead of print, 2020 May 21]
Article
CAS
PubMed
Google Scholar
Reddy KR (2020) SARS-CoV-2 and the liver: considerations in hepatitis B and hepatitis C infections. Clin Liver Dis 15(5):191–194. https://doi.org/10.1002/cld.970
Article
Google Scholar
Gao F, Zheng KI, Wang XB et al (2020) Metabolic associated fatty liver disease increases COVID-19 disease severity in non-diabetic patients. J Gastroenterol Hepatol. https://doi.org/10.1111/jgh.15112 [published online ahead of print, 2020 May 21]
Gao F, Zheng KI, Wang XB, Yan HD, Sun QF, Pan KH, Wang TY, Chen YP, George J, Zheng MH (2020) Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients. J Gastroenterol Hepatol 21. https://doi.org/10.1111/jgh.15112 PMID: 32436622
Odjidja EN, Longo VL, Rizzatti G, Bandoh S (2020) Coronavirus disease 2019 and viral hepatitis coinfection: provide guidelines for integrated screening and treatment. J Med Virol. https://doi.org/10.1002/jmv.26021 Accepted Author Manuscript
Mantovani A, Beatrice G, Dalbeni A (2020) Coronavirus disease 2019 and prevalence of chronic liver disease: a meta-analysis. Liver Int 00(6):1–5. https://doi.org/10.1111/liv.14465
Article
CAS
Google Scholar
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, and the Northwell COVID-19 Research Consortium, Barnaby DP, Becker LB, Chelico JD, Cohen SL, Cookingham J, Coppa K, Diefenbach MA, Dominello AJ, Duer-Hefele J, Falzon L, Gitlin J, Hajizadeh N, Harvin TG, Hirschwerk DA, Kim EJ, Kozel ZM, Marrast LM, Mogavero JN, Osorio GA, Qiu M, Zanos TP (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 323(20):2052–2059. https://doi.org/10.1001/jama.2020.6775
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen X, Jiang Q, Ma Z, et al (2020) Clinical characteristics of hospitalized patients with SARS-CoV-2 and hepatitis B virus coinfection. medRxiv. Available at: https://doi.org/10.1101/2020.03.23.20040733.10
Blach S, Kondili LA, Aghemo A, Cai Z, Dugan E, Estes C, Gamkrelidze I, Ma S, Pawlotsky JM, Razavi-Shearer D, Razavi H, Waked I, Zeuzem S, Craxi A (2021) Impact of COVID-19 on global HCV elimination efforts. J Hepatol 74(1):31–36. https://doi.org/10.1016/j.jhep.2020.07.042
Article
CAS
PubMed
Google Scholar
Guss D, Sherigar J, Rosen P, Mohanty SR (2018) Diagnosis and management of hepatitis C infection in primary care settings. J Gen Intern Med 33(4):551–557. https://doi.org/10.1007/s11606-017-4280-y
Article
PubMed
PubMed Central
Google Scholar
Karimi-Sari H, Rezaee-Zavareh MS (2020) COVID-19 and viral hepatitis elimination programs: are we stepping backward? Liver Int. https://doi.org/10.1111/liv.14486 [published online ahead of print, 2020 Apr 22]
Ji D, Qin E, Xu J, Zhang D, Cheng G, Wang Y, Lau G (2020) Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study. J Hepatol 73(2):451–453. https://doi.org/10.1016/j.jhep.2020.03.044. Epub 2020 Apr 8.
Eslam M, Sanyal AJ, George J, Sanyal A, Neuschwander-Tetri B, Tiribelli C, Kleiner DE, Brunt E, Bugianesi E, Yki-Järvinen H, Grønbæk H, Cortez-Pinto H, George J, Fan J, Valenti L, Abdelmalek M, Romero-Gomez M, Rinella M, Arrese M, Eslam M, Bedossa P, Newsome PN, Anstee QM, Jalan R, Bataller R, Loomba R, Sookoian S, Sarin SK, Harrison S, Kawaguchi T, Wong VWS, Ratziu V, Yilmaz Y, Younossi Z (2020) MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158(7):1999–2014. https://doi.org/10.1053/j.gastro.2019.11.312
Article
CAS
PubMed
Google Scholar
Younossi ZM (2019) Non-alcoholic fatty liver disease - a global public health perspective. J Hepatol 70(3):531–544. https://doi.org/10.1016/j.jhep.2018.10.033
Article
PubMed
Google Scholar
Taylor RS, Taylor RJ, Bayliss S, Hagström H, Nasr P, Schattenberg JM, Ishigami M, Toyoda H, Wai-Sun Wong V, Peleg N, Shlomai A, Sebastiani G, Seko Y, Bhala N, Younossi ZM, Anstee QM, McPherson S, Newsome PN (2020) Association between fibrosis stage and outcomes of patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Gastroenterology 158(6):1611–1625. https://doi.org/10.1053/j.gastro.2020.01.043
Article
CAS
PubMed
Google Scholar
Feng G, Zheng KI, Yan QQ, Rios RS, Targher G, Byrne CD, Poucke SV, Liu WY, Zheng MH (2020) COVID-19 and liver dysfunction: current insights and emergent therapeutic strategies. J Clin Transl Hepatol 8(1):18–24. https://doi.org/10.14218/JCTH.2020.00018
Article
PubMed
PubMed Central
Google Scholar
Van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG et al (2008) Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 48(2):449–457. https://doi.org/10.1002/hep.22350
Article
PubMed
Google Scholar
Chen F, Esmaili S, Rogers GB, Bugianesi E, Petta S, Marchesini G et al (2019) Lean NAFLD: a distinct entity shaped by differential metabolic adaptation. Hepatology 71(4):1213–1227
Article
Google Scholar
Targher G, Mantovani A, Byrne CD et al (2020) Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores. Gut:gutjnl-2020-321611. https://doi.org/10.1136/gutjnl-2020-321611 [published online ahead of print, 2020 May 15]
Biquard L, Valla D, Rautou PE (2020) No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease. J Hepatol:S0168-8278(20)30279-8. https://doi.org/10.1016/j.jhep.2020.04.035 [published online ahead of print, 2020 Apr 30]
Cheung K, Hung IF, Chan PP, Lung KC, Tso E, Liu R (2020) Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis. Gastroenterology:S0016-5085(20)30448-0. https://doi.org/10.1053/j.gastro.2020.03.065
Honce R, Schultz-Cherry S (2019) Impact of obesity on influenza A virus pathogenesis, immune response, and evolution. Front Immunol 10:1071. https://doi.org/10.3389/fimmu.2019.01071 eCollection 2019
Article
CAS
PubMed
PubMed Central
Google Scholar
Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, Vierling JM (2010) Diagnosis and management of autoimmune hepatitis. Hepatology 51(6):2193–2213. https://doi.org/10.1002/hep.23584
Article
CAS
PubMed
Google Scholar
Forns X, Navasa M (2020) Liver transplant immunosuppression during the COVID-19 pandemic. Gastroenterol Hepatol 43(8):457–463. https://doi.org/10.1016/j.gastrohep.2020.06.003 Epub 2020 Jun 12. PMID: 32646657; PMCID: PMC7290227. English, Spanish
Article
PubMed
PubMed Central
Google Scholar
Mack, C.L., Adams, D., Assis, D.N., Kerkar, N., Manns, M.P., Mayo, M.J., Vierling, J.M., Alsawas, M., Murad, M.H. and Czaja, A.J. (2020), Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology 72:671–722. https://doi.org/10.1002/hep.31065.
Lleo A, Invernizzi P, Lohse AW, Aghemo A, Carbone M (2020) Highlights for management of patients with autoimmune liver disease during COVID-19 pandemia. J Hepatol 73(2):453–455. https://doi.org/10.1016/j.jhep.2020.04.002
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513. https://doi.org/10.1016/S0140-6736(20)30211-7
Article
CAS
PubMed
PubMed Central
Google Scholar
Wander P, Epstein M, Bernstein D (2020) COVID-19 presenting as acute hepatitis. Am J Gastroenterol 115(6):941–942. https://doi.org/10.14309/ajg.0000000000000660 PMID: 32301760; PMCID: PMC7172489
Article
PubMed
Google Scholar
Di Giorgio A, Nicastro E, Speziani C, De Giorgio M, Magro B, Fagiuoli S, Antiga LD (2020) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID
Google Scholar
Di Giorgio A, Nicastro E, Speziani C, De Giorgio M, Pasulo L, Magro B, Fagiuoli S, D’Antiga L (2020) Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern Italy. J Hepatol 73(3):702–705. https://doi.org/10.1016/j.jhep.2020.05.008
Fix OK, Hameed B, Fontana RJ, Kwok RM, McGuire BM, Mulligan DC, Pratt DS, Russo MW, Schilsky ML, Verna EC, Loomba R, Cohen DE, Bezerra JA, Reddy KR, Chung RT (2020) Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement. Hepatology 72(1):287–304. https://doi.org/10.1002/hep.31281.
Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). 2021 Jan 16. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. PMID: 32150360.
El Kassas M, Alboraie M, Al Balakosy A et al (2020) Liver transplantation in the era of COVID-19. Arab J Gastroenterol:S1687-1979(20)30053-8. https://doi.org/10.1016/j.ajg.2020.04.019 [published online ahead of print, 2020 May 12]
Hamid S, Alvares da Silva MR, Burak KW, Chen T, Drenth J, Esmat G, Gaspar R, LaBrecque D, Lee A, Macedo G, McMahon B, Ning Q, Reau N, Sonderup M, van Leeuwen DJ, Armstrong DMA, Yurdaydin C (2021) WGO Guidance for the care of patients with COVID-19 and liver disease. J Clin Gastroenterol 55(1):1–11. https://doi.org/10.1097/MCG.0000000000001459
Article
CAS
PubMed
Google Scholar
Radford-Smith DE, Powell EE, Powell LW (2018) Haemochromatosis: a clinical update for the practising physician. Intern Med J 48(5):509–516. https://doi.org/10.1111/imj.13784
Article
CAS
PubMed
Google Scholar
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, China Novel Coronavirus Investigating and Research Team (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382(8):727–733. https://doi.org/10.1056/NEJMoa2001017
Article
CAS
PubMed
PubMed Central
Google Scholar
Rametta R, Meroni M, Dongiovanni P (2020) From environment to genome and back: a lesson from HFE mutations. Int J Mol Sci 21(10):E3505
Article
Google Scholar
Kowdley KV, Brown KE, Ahn J, Sundaram V (2019) ACG Clinical Guideline: hereditary hemochromatosis. Am J Gastroenterol 114(8):1202–1218. https://doi.org/10.14309/ajg.0000000000000315
Article
PubMed
Google Scholar
Ferenci P (2017) Diagnosis of Wilson disease. Handb Clin Neurol 142:171–180. https://doi.org/10.1016/B978-0-444-63625-6.00014-8
Article
PubMed
Google Scholar
Huster D (2018) Wilson disease. Internist (Berl) 59(2):159–174
Article
CAS
Google Scholar
Lima TG, Benevides FLN, Esmeraldo Filho FL, Farias IS, Dourado DXC, Fontenele EGP et al (2019) Treatment of iron overload syndrome: a general review. Rev Assoc Med Bras (1992) 65(9):1216–1222
Article
Google Scholar
Mohamed AA, Mohamed N, Mohamoud S, Zahran FE, Khattab RA, El-Damasy DA et al (2020) SARS-CoV-2: the path of prevention and control. Infect Disord Drug Targets. https://doi.org/10.2174/1871526520666200520112848 Online ahead of print
https://www.alpha1.org/alphas-friends-family/resources/covid-19-updates/. Acssesed 28 Dec 2020.
Boettler T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Cornberg M, Berg T (2020) Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. JHEP Rep 2(3):100113. https://doi.org/10.1016/j.jhepr.2020.100113
Article
PubMed
PubMed Central
Google Scholar
Maurice JB, Brodkin E, Arnold F, Navaratnam A, Paine H, Khawar S, Dhar A, Patch D, O’Beirne J, Mookerjee R, Pinzani M, Tsochatzis E, Westbrook RH (2016) Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices. J Hepatol 65(5):899–905. https://doi.org/10.1016/j.jhep.2016.06.021
Article
PubMed
Google Scholar
Chandok N, Watt KDS (2010) Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin Proc 85(5):451–458. https://doi.org/10.4065/mcp.2009.0534
Article
PubMed
PubMed Central
Google Scholar
Aggarwal A, Puri K, Liangpunsakul S (2014) Deep vein thrombosis and pulmonary embolism in cirrhotic patients: systematic review. World J Gastroenterol 20(19):5737–5745. https://doi.org/10.3748/wjg.v20.i19.5737 Available from: URL: http://www.wjgnet.com/1007-9327/full/v20/i19/5737.htm
Article
PubMed
PubMed Central
Google Scholar
Harrison C. Coronavirus puts drug repurposing on the fast track. 2020. Available from: https://www.nature.com/articles/d41587-020-00003-1. Cited March 12th 2020
(2012) Hydroxychloroquine. LiverTox: clinical and research information on drug-induced liver injury. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda. doi: https://doi.org/10.1007/s40278-019-58063-3
Casado JL, Del Palacio M, Moya J, Rodriguez JM, Moreno A, Perez-Elías MJ et al (2011) Safety and pharmacokinetics of lopinavir in HIV/HCV coinfected patients with advanced liver disease. HIV Clin Trials 12(5):235–243. https://doi.org/10.1310/hct1205-235
Article
CAS
PubMed
Google Scholar
Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A (2020) Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med 382(24):2327–2336. https://doi.org/10.1056/NEJMoa2007016
Article
CAS
PubMed
Google Scholar
Genovese MC, Kremer JM, van Vollenhoven RF, Alten R, Scali JJ, Kelman A, Dimonaco S, Brockwell L (2017) Transaminase levels and hepatic events during tocilizumab treatment: pooled analysis of long-term clinical trial safety data in rheumatoid arthritis. Arthritis Rheumatol 69(9):1751–1761. https://doi.org/10.1002/art.40176
Article
CAS
PubMed
Google Scholar
Singal AG, Mittal S, Yerokun OA, Ahn C, Marrero JA, Yopp AC, Parikh ND, Scaglione SJ (2017) Hepatocellular carcinoma screening associated with early tumor detection and improved survival among patients with cirrhosis in the US. Am J Med 130(9):1099–1106.e1. https://doi.org/10.1016/j.amjmed.2017.01.021
Article
PubMed
Google Scholar
(2018) European Association for the Study of the Liver EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 69(1):182–236. https://doi.org/10.1016/j.jhep.2018.03.019
Singh S, Khan A (2020) Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the United States: a multicenter research network study. Gastroenterology 159(2):768–771.e3. https://doi.org/10.1053/j.gastro.2020.04.064 PMID: 32376408
Article
CAS
PubMed
PubMed Central
Google Scholar
Kudo M, Kurosaki M, Ikeda M, Aikata H, Hiraoka A, Torimura T, Sakamoto N (2020) Treatment of hepatocellular carcinoma during the COVID-19 outbreak: the Working Group report of JAMTT-HCC. Hepatol Res 50(9):1004–1014. https://doi.org/10.1111/hepr.13541 Epub 2020 Jul 20. PMID: 32583525; PMCID: PMC7361293
Article
CAS
PubMed
Google Scholar
Adam R, Karam V, Delvart V, O’Grady J, Mirza D, Klempnauer J et al (2012) Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol 57(3):675–688. https://doi.org/10.1016/j.jhep.2012.04.015
Article
PubMed
Google Scholar
Dutkowski P, De Rougemont O, Mullhaupt B, Clavien PA (2010) Current and future trends in liver transplantation in Europe. Gastroenterology 138(3):802–809, e1–e4. https://doi.org/10.1053/j.gastro.2010.01.030
Article
PubMed
Google Scholar
Van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al (2020) Aerosol and surface stability of SARS-COV-2 as compared with SARS-COV-1. N Engl J Med 382:1564–1567. https://www.nejm.org/doi/pdf/10.1056/NEJMc2004973.
Saigal S, Gupta S, Sudhindran S, Goyal N, Rastogi A et al (2020) Liver transplantation and COVID-19 (coronavirus) infection: guidelines of the liver transplant Society of India (LTSI). Hepatol Int:1–3. https://doi.org/10.1007/s12072-020-10041-1 [Epub ahead of print]
D’Antiga L (2020) Coronaviruses and immunosuppressed patients. The facts during the third epidemic. Liver Transpl. https://doi.org/10.1002/lt.25756 published online March 20
Bhoori S, Rossi RE, Citterio D, Mazzaferro V (2020) COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy. https://doi.org/10.1016/S2468-1253(20)30116-3
Book
Google Scholar
Belli LS, Fondevila C, Cortesi PA, Conti S, Karam V, Adam R, Coilly A, Ericzon BG, Loinaz C, Cuervas-Mons V, Zambelli M, Llado L, Diaz F, Invernizzi F, Patrono D, Faitot F, Bhooori S, Pirenne J, Perricone G, Magini G, Castells L, Detry O, Cruchaga PM, Colmenero J, Berrevoet F, Rodriguez G, Ysebaert D, Radenne S, Metselaar H, Morelli C, De Carlis L, Polak WG, Duvoux C, all the centres contributing to the ELITA-ELTR COVID-19 Registry (2020) Protective role of tacrolimus, deleterious role of age and comorbidities in liver transplant recipients with Covid-19: results from the ELITA/ELTR multi-center European study. Gastroenterology:S0016-5085(20)35514-1. https://doi.org/10.1053/j.gastro.2020.11.045 Epub ahead of print. PMID: 33307029; PMCID: PMC7724463
Fix OK, Hameed B, Fontana RJ et al (2020) Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD Expert Panel Consensus Statement. Hepatology. https://doi.org/10.1002/hep.31281 [published online ahead of print, 2020 Apr 16]
World Health Organization: Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19). Interim guidance. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus2019/technicalguidance/infection-prevention-and-control. Accessed 12 Apr 2020
American Society of Transplantation. 2019-nCoV (coronavirus): FAQs for organ donation and transplantation. 2020. https://www.myast.org/sites/default/files/COVID19%20FAQ%20Tx%20Centers%2003.20.2020-FINAL.pdf. Accessed May 2020.
Google Scholar
National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines. 2020. https://www.covid19treatmentguidelines.nih.gov. Accessed May 2020.
Google Scholar
Fix OK, Serper M (2020) Telemedicine and telehepatology during the COVID-19 pandemic. Clin Liver Dis 15(5):187–190. https://doi.org/10.1002/cld.971
Article
Google Scholar
Arora S, Thornton K, Murata G, Deming P, Kalishman S, Dion D et al (2011) Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med 364(23):2199–2207. https://doi.org/10.1056/NEJMoa1009370
Article
CAS
PubMed
Google Scholar
Cuadrado A, Llerena S, Cobo C, Pallás JR, Mateo M, Cabezas J et al (2018) Microenvironment eradication of hepatitis C: a novel treatment paradigm. Am J Gastroenterol 113:1639–1648. (Abstracts. Hepatol Int. 2020;14(1):1–470). https://doi.org/10.1007/s12072-020-10030-4
Article
PubMed
Google Scholar
Cuadrado A, Llerena S, Cobo C, Pallás JR, Mateo M, Cabezas J, Fortea JI, Alvarez S, Pellón R, Crespo J, Echevarría S, Ayesa R, Setién E, Lopez-Hoyos M, Crespo-Facorro B, Agüero J, Chueca N, Garcia F, Calleja JL, Crespo J (2018) Microenvironment eradication of hepatitis C: a novel treatment paradigm. Am J Gastroenterol 113(11):1639–1648. https://doi.org/10.1038/s41395-018-0157-x PMID: 29946175
Article
PubMed
Google Scholar
Tapper EB, Asrani SK (2020) The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care. J Hepatol:S0168-8278(20)30217-8. https://doi.org/10.1016/j.jhep.2020.04.005 [published online ahead of print, 2020 Apr 13]
John BV, Love E, Dahman B et al (2019) Use of telehealth expedites evaluation and listing of patients referred for liver transplantation. Clin Gastroenterol Hepatol:S1542-3565(19)31501-0. https://doi.org/10.1016/j.cgh.2019.12.021 [published online ahead of print, 2019 Dec 27]
Akhtar M, Van Heukelom PG, Ahmed A et al (2018) Telemedicine physical examination utilizing a consumer device demonstrates poor concordance with in-person physical examination in emergency department patients with sore throat: a prospective blinded study. Telemed J E Health 24(10):790–796. https://doi.org/10.1089/tmj.2017.0240
Article
PubMed
PubMed Central
Google Scholar
Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, Diaz G, Cohn A, Fox L, Patel A, Gerber SI, Kim L, Tong S, Lu X, Lindstrom S, Pallansch MA, Weldon WC, Biggs HM, Uyeki TM, Pillai SK, Washington State 2019-nCoV Case Investigation Team (2020) First case of 2019 novel coronavirus in the United States. N Engl J Med 382(10):929–936. https://doi.org/10.1056/NEJMoa2001191
Article
CAS
PubMed
PubMed Central
Google Scholar
Beigel JH, Tomashek KM, Dodd LE et al (2020) Remdesivir for the treatment of Covid-19 - preliminary report. N Engl J Med:NEJMoa2007764. https://doi.org/10.1056/NEJMoa2007764 [published online ahead of print, 2020 May 22]
COVID-19 Drug interactions. 2020. Available from: http://www.covid19-druginteractions.org/. Cited March 16th 2020
Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, Labella A, Manson DK, Kubin C, Barr RG, Sobieszczyk ME, Schluger NW (2020) Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med 382(25):2411–2418. https://doi.org/10.1056/NEJMoa2012410
Article
CAS
PubMed
Google Scholar
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C (2020) A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 382(19):1787–1799. https://doi.org/10.1056/NEJMoa2001282
Article
PubMed
Google Scholar
Simonovich VA, Burgos Pratx LD, Scibona P, Beruto MV, Vallone MG, Vazquez C, Savoy N, Giunta DH, Perez LG, Sanchez MDL, Gamarnik AV, Ojeda DS, Santoro DM, Camino PJ, Antelo S, Rainero K, Vidiella GP, Miyazaki EA, Cornistein W, Trabadelo OA, Ross FM, Spotti M, Funtowicz G, Scordo WE, Losso MH, Ferniot I, Pardo PE, Rodriguez E, Rucci P, Pasquali J, Fuentes NA, Esperatti M, Speroni GA, Nannini EC, Matteaccio A, MichelangeloHG, Follmann D, Lane HC, Belloso WH, PlasmAr Study Group A randomized trial of convalescent plasma in Covid-19. https://pubmed.ncbi.nlm.nih.gov/33232588.
Anup A, Aparna M, Gunjan K, Pranab C, Tarun B, Pankaj M et al (2020) Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial). BMJ 371:m3939. https://doi.org/10.1136/bmj.m4232.
Chen LF, Mo YQ, Jing J, Ma JD, Zheng DH, Dai L (2017) Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation. Int J Rheum Dis 20(7):859–869. https://doi.org/10.1111/1756-185X.13010
Article
CAS
PubMed
Google Scholar